Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis

Enzo Ierardi; Floriana Giorgio; Mariangela Zotti; Rosa Rosania; Mariabeatrice Principi; Stefania Marangi; Nicola Della Valle; Vincenzo De Francesco; Alfredo Di Leo; Marcello Ingrosso; Carmine Panella

doi:10.1136/jcp.2010.086892

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via ACP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

75th Anniversary

For authors

About

Call for Papers
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via ACP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Original article

Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Ierardi E, Giorgio F, Zotti M, et al

Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis

Journal of Clinical Pathology 2011;64:968-972.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password